Ceribell CBLL

Ceribell, Inc. · Nasdaq · Electromedical & Electrotherapeutic Apparatus

$27.220.00%close on Oct. 28, 2026 · volume 742K · Yahoo Finance

Price, last 47 sessions

$24.00$26.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $27.68 · low $23.15

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 1, 2026Raymond Woo
Chief Technology Officer
Sold
10b5-1 plan
4,887$24.38$119,145
Sept. 15, 2026Xingjuan Chao
President and CEO, director
Sold
10b5-1 plan
20,846$25.03$521,775
Sept. 15, 2026Scott Blumberg
Chief Financial Officer
Sold
10b5-1 plan
846$25.00$21,150
Sept. 8, 2026David Foehr
Senior VP, Finance and PAO
Sold
10b5-1 plan
9,255$24.25
$24.25-$24.26
$224,451
Sept. 8, 2026Raymond Woo
Chief Technology Officer
Sold
10b5-1 plan
4,887$24.33$118,901
Sept. 2, 2026Xingjuan Chao
President and CEO, director
Sold
10b5-1 plan
39,540$24.61$973,079
Sept. 2, 2026Scott Blumberg
Chief Financial Officer
Sold
10b5-1 plan
652$25.00$16,300
Aug. 24, 2026David Foehr
Senior VP, Finance and PAO
Sold
10b5-1 plan
859$23.95$20,573
Aug. 21, 2026Joseph S. Manni
Chief Revenue Officer
Sold1,361$24.02$32,691
Aug. 21, 2026David Foehr
Senior VP, Finance and PAO
Sold
10b5-1 plan
993$24.02$23,852
Aug. 21, 2026Raymond Woo
Chief Technology Officer
Sold1,979$24.02$47,536
Aug. 21, 2026Scott Blumberg
Chief Financial Officer
Sold1,521$24.02$36,534

Latest 12 of 19. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 26 →